Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Awards Granted (Details)

v3.21.2
Schedule of Stock Awards Granted (Details)
3 Months Ended
Sep. 30, 2021
USD ($)
$ / shares
shares
Share-based Payment Arrangement [Abstract]  
Number of Shares, Outstanding, Beginning balance | shares 604,404
Weighted Average Exercise Price, Outstanding, Beginning balance | $ / shares $ 2.18
Weighted Average Remaining Contractual Term (Years), Outstanding, Beginning balance 4 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding, Beginning balance | $ $ 2,802,420
Number of Shares, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Number of Shares, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Number of Shares, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Number of Shares, Outstanding, Ending balance | shares 604,404
Weighted Average Exercise Price, Outstanding, Ending balance | $ / shares $ 2.18
Weighted Average Remaining Contractual Term (Years), Outstanding, Ending balance 4 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding, Ending balance | $ $ 2,639,230
Number of Shares, Exercisable | shares 62,664
Weighted Average Exercise Price, Exercisable | $ / shares $ 2.18
Weighted Average Remaining Contractual Term (Years), Exercisable 4 years 4 months 24 days
Aggregate Intrinsic Value, Exercisable | $ $ 273,633